| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0002 | 1 |